Improved Prognostic Stratification with the FIGO 2023 Staging System in Endometrial Cancer: Real-World Validation in 2969 Patients
The FIGO 2023 staging revision improves prognostic accuracy in endometrial cancer by integrating histopathologic and molecular risk factors. These refinements enhance risk stratification and may support more individualized treatment strategies.
Authors
- Yoo-Young Lee (ORCID: https://orcid.org/0000-0001-5902-9877)
- Byoung‐Gie Kim (ORCID: https://orcid.org/0000-0002-0572-8450)
- Chel Hun Choi (ORCID: https://orcid.org/0000-0002-0199-6669)
- Jeong‐Won Lee (ORCID: https://orcid.org/0000-0002-6110-4909)
- Soo-Min Kim (ORCID: https://orcid.org/0000-0002-2368-3057)
- Tae‐Joong Kim (ORCID: https://orcid.org/0000-0002-9693-9164)
- Jun‐Hyeong Seo (ORCID: https://orcid.org/0000-0002-8044-3084)
Institutions
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3390/cancers17172871
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00